Across the TCGA database, the expression of KLHL5 correlates with prognosis in mammary, brain, soft tissue, colorectal, lung, ovarian, and blood cancer (Figures 2A–H). Here, KLHL5 is linked to hematopoietic and lymphoid system neoplasm.